Sign Up to like & get
recommendations!
1
Published in 2021 at "Microbial drug resistance"
DOI: 10.1089/mdr.2020.0294
Abstract: Carbapenems, although originally introduced against multidrug-resistant (MDR) Gram negative bacilli (GNB), are now advocated for initial empiric use resulting in increasing carbapenem-resistant (CR) GNB. In this study, we analyzed the frequencies of CR-GNB and compared…
read more here.
Keywords:
negative bacilli;
gram negative;
gnb;
pan drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00053-22
Abstract: Candida auris is an urgent antimicrobial resistance threat due to its global emergence, high mortality, and persistent transmissions. Nearly half of C. auris clinical and surveillance cases in the United States are from the New…
read more here.
Keywords:
candida auris;
pan drug;
resistance;
drug resistant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24076784
Abstract: Recently, urinary tract infection (UTI) triggered by bacteria carrying pan-drug-resistant genes, including carbapenem resistance gene blaNDM and blaKPC, colistin resistance gene mcr-1, and tet(X) for tigecycline resistance, have been reported, posing a serious challenge to…
read more here.
Keywords:
system;
pan drug;
uti samples;
detection ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pathogens"
DOI: 10.3390/pathogens12020286
Abstract: Acinetobacter baumannii (AB) has evolved over the last decades as a major problem in carbapenem-resistant gram-negative nosocomial infections, associated with high mortality rates especially in the intensive care unit (ICU). Recent reports highlight the increasing…
read more here.
Keywords:
containing regimens;
pan drug;
fosfomycin containing;
acinetobacter baumannii ... See more keywords